Gennex Laboratories profit increases 41.57% in (Q3) FY 2020-21

Source

Team Infinities:

Gennex Laboratories Limited BSE Security Code:531739 has declared its 3rd(third) quarter unaudited consolidated financial report from the month of October, 2020 to the month of December, 2020; for the fiscal year 2020-21.

Revenue Reported by Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
156.14 151.32 149.07 439.40 449.35
Calculated Revenue of Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
4.82 3.19%(Revenue Increase) 7.07 4.74%(Revenue Increase) 9.95 2.21%(Revenue Decrease)

Revenue: Gennex Laboratories Limited's financial report shows that the company's revenue increased by 3.19% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for revenue increase of Rs.4.82 millions, as the company posted revenue of Rs.156.14 millions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported revenue of Rs.151.32 millions.
The result also shows that the company's revenue increased by 4.74% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for revenue increase of Rs.7.07 millions; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted revenue of Rs.149.07 millions.
The company also reported that its revenue decreased by 2.21% in 9 months end(April, 2020 - December, 2020) for revenue decrease of Rs.9.95 millions, since the company reported revenue of Rs.439.40 millions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted revenue of Rs.449.35 millions.

Gross Margin(%) Reported by Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
31.14 37.83 37.18 43.63 33.33
Calculated Gross Margin(%) of Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
6.70 17.70%(GM Decrease) 6.04 16.25%(GM Decrease) 10.30 30.88%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 17.70% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for 6.70% GM decrease, as the company reported 31.14% GM; in compare to previous quarter(July, 2020 - September, 2020) when the company reported 37.83% GM.
The result also indicates, the company's GM decreased by 16.25% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for 6.04% GM decrease; in compare to corresponding quarter(October, 2019 - December, 2019) when the company reported 37.18% GM.
The company also reported that its GM increased by 30.88% in 9 months end(April, 2020 - December, 2020) for 10.30% GM increase, since the company reported 43.63% GM; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company reported 33.33% GM.

EBITDA Reported by Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
12.58 9.59 5.33 28.22 23.69
Calculated EBITDA of Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
2.99 31.18%(EBITDA Increase) 7.25 136.02%(EBITDA Increase) 4.53 19.12%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 31.18% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.2.99 millions, as the company posted EBITDA of Rs.12.58 millions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EBITDA of Rs.9.59 millions.
The result also shows that the company's EBITDA increased by 136.02% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.7.25 millions; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EBITDA of Rs.5.33 millions.
The company also reported that its EBITDA increased by 19.12% in 9 months end(April, 2020 - December, 2020) for EBITDA increase of Rs.4.53 millions, since the company reported EBITDA of Rs.28.22 millions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EBITDA of Rs.23.69 millions.

Profit and Loss Reported by Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
12.26(Profit ) 8.66(Profit ) 1.99(Profit ) 24.60(Profit ) 15.54(Profit )
Calculated Profit and Loss of Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
3.60 41.57%(Profit Increase) 10.27 516.08%(Profit Increase) 9.06 58.30%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 41.57% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for profit increase of Rs.3.60 millions, as the company posted profit of Rs.12.26 millions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported profit of Rs.8.66 millions. Please note that the company has received a Tax Credit worth Rs.3.3 million in the current quarter.
The result also shows that the company's profit increased by 516.08% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for profit increase of Rs.10.27 millions; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted profit of Rs.1.99 millions.
The company also reported that its profit increased by 58.30% in 9 months end(April, 2020 - December, 2020) for profit increase of Rs.9.06 millions, since the company reported profit of Rs.24.60 millions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted profit of Rs.15.54 millions.

EPS Reported by Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
0.10 0.07 0.02 0.19 0.12
Calculated EPS of Gennex Laboratories Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
0.03 42.65%(EPS Increase) 0.08 506.25%(EPS Increase) 0.07 57.72%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 42.65% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EPS increase of Rs.0.03, as the company posted EPS of Rs.0.10; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EPS of Rs.0.07.
The result also shows that the company's EPS increased by 506.25% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EPS increase of Rs.0.08; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EPS of Rs.0.02.
The company also reported that its EPS increased by 57.72% in 9 months end(April, 2020 - December, 2020) for EPS increase of Rs.0.07, since the company reported EPS of Rs.0.19; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EPS of Rs.0.12.

 


***All amounts are given in Million Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.